The global demand for Enteral Feeding Formulas Market is presumed to reach the market size of nearly USD 11.58 MN by 2028 from USD 7.4 MN in 2021 with a CAGR of 6.6% under the study period 2022 - 2028.
Enteral feeding formulas are also known as tube feeding formula considered for medical ailments such as cancer, eating inability, chronic illness, life-threatening injuries, and stroke or attacks. The term enteral feeding describes a procedure in which food is intake through the gastrointestinal tract. The stomach, esophagus, intestines, and mouth constitute the gastrointestinal tract. The nutrition taken via a tube goes directly to the stomach & small intestine. This form of feeding method is used as a supplement. This feeding method enables patients to receive the nutrition that keeps their gastrointestinal tract active.
Market Dynamics
The robust growth of the enteral feeding formula market is driven by the increasing prevalence of cancer, dementia, stroke, multiple sclerosis, chronic obstructive pulmonary disease (COPD), liver ailments and other chronic diseases. The rise in preterm births is another major factor augmenting the market growth. The demand for enteral feeding formulas in oncological applications is likely to be fueled by the rising incidence of cancer, the transition from hospitals to outpatient care settings, and the growing acceptance of enteral feeding formulas as an efficient substitute for parenteral nutrition among cancer patients.
The research report covers Porter’s Five Forces Model, Market Attractiveness Analysis, and Value Chain analysis. These tools help to get a clear picture of the industry’s structure and evaluate the competition attractiveness at a global level. Additionally, these tools also give an inclusive assessment of each segment in the global market of enteral feeding formulas. The growth and trends of enteral feeding formulas industry provide a holistic approach to this study.
Market Segmentation
This section of the enteral feeding formulas market report provides detailed data on the segments at country and regional level, thereby assisting the strategist in identifying the target demographics for the respective product or services with the upcoming opportunities.
By Product
- Standard Formula
- Disease-Specific Formula
By Flow Type
- Intermittent Feeding Flow
- Continuous Feeding Flow
By Stage
By Indication
- Alzheimer’S
- Nutrition Deficiency
- Cancer Care
- Diabetes
- Chronic Kidney Diseases
- Orphan Diseases
- Dysphagia
- Pain Management
- Malabsorption/GI Disorder/Diarrhea
- Others
By End-User
- Hospitals (Cardiology, Neurology, Critical Care (ICU), Oncology, Others)
- Home Care
By Sales Channel
- Online Sales
- Institutional Sales
- Retail Sales
Regional Analysis
This section covers the regional outlook, which accentuates current and future demand for the Enteral Feeding Formulas market across North America, Europe, Asia-Pacific, Latin America, and Middle East & Africa. Further, the report focuses on demand, estimation, and forecast for individual application segments across all the prominent regions.
Global Enteral Feeding Formulas Market Share by Region (Representative Graph)
The research report also covers the comprehensive profiles of the key players in the market and an in-depth view of the competitive landscape worldwide. The major players in the enteral feeding formulas market include Abbott, Danone SA, Fresenius Kabi, Nestlé, Victus, Inc., Primus Pharmaceuticals, Inc., Meiji Holdings. Co., Ltd and Rickett Benckiser Group Plc. This section consists of a holistic view of the competitive landscape that includes various strategic developments such as key mergers & acquisitions, future capacities, partnerships, financial overviews, collaborations, new product developments, new product launches, and other developments.
In case you have any custom requirements, do write to us. Our research team can offer a customized report as per your need.
